Methods to reduce the risk of a cardiovascular Event in a subject with statin Therapy

• 收藏
• 分享

专利权人:

AMARIN PHARMACEUTICALS IRELAND LIMITED

发明人:

SONI PARESH

申请号：

CO15017153

公开号：

CO7190236A2

申请日:

2015.01.28

申请国别(地区):

CO

年份:

2015

代理人:

摘要：

The invention refers to the form of oral solid-state drug management, including 5-chloro-n - (- (5S) - 2-oxo-3 - [4 - (3-oxo-4-morfolini) phenyl] - 1, 3-oxazolidin-5-il -, methyl) - 2-endosulfan (rivaroxab, active compound (I)),It is characterized by rapid release of some active compounds (I) and partial controlled release (correction, delay, delay),Procedures for preparation, use as drugs and for prevention, secondary prevention or treatment of disordersVer anexos

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/